glp-1 available in canada Health approves Rybelsus, the first oral pill to lower cardiovascular risk adults with Type 2 diabetes. #longevity #GLP1 #diabetes #cardiometabolic #hearthealth #metabolichealth #obesitycare #digitalhealth #biotechnews #healthinnovation Generic of Novo's GLP-1 arrives

Its the most studied, reliable, and bioavailable oral glutathione on the market

Tracking biomarkers across these systems enables better care 85%+ Muscle mass preserved With guidance, patients preserve lean muscle through targeted protein and strength protocols Most GLP-1 programs fall short Without clinical support Higher risk of losing lean tissue Muscle loss Derail treatment adherence Side effects Weight loss without metabolic health No metabolic tracking Most quit within 6 months Early discontinuation Multi-system intervention Success measured across the body Clinician-led care with ongoing oversight Dosing, tolerance, and response actively managed Decisions guided by biological feedback Biomarkers and symptoms used to protect long-term health Long-term healthspan Designed to support aging, resilience, and metabolic health Clinician-guided GLP-1 treatment Your clinician reviews your medical history and goals to determine eligibility and guide the right treatment choice, including injectable or oral options

This effect was abrogated by inhibiting NOSs or guanylate cyclase, implicating NO/cGMP signaling pathway in this process ( Figure 1 )

Always consult your healthcare provider before beginning any new wellness routine